UC Irvine Today
Biosimiar medical products offer the promise of enhanced medical therapies at sustainable pricing. However, the scientific and economic challenges associated with biosimilars threaten to impede the promise of such medical advances. New incentive strategies are needed to advance development in this area. To address such challenges, speakers at this conference will explore the legal and regulatory frameworks needed to encourage innovative development and distribution of biosimilar products.
Friday, February 8 at 8:30am to 5:00pm
UCI Law, MPAA 420, MPAA 420 401 E. Peltason Drive, Suite 1000, Irvine, CA 92697-8000